Article Listing - F-Star and Merck Serono in up to 492 million-euro collaboration on novel targeted biologics

GLOBAL MARKETS AND FACTORS FOR SUCCESS

6 April 1992

As the geographical borders between pharmaceutical markets begin to disappear, so do the differences among the critical success factors for...

HERBAL MEDICINES IN ASIA 1992-96

6 April 1992

The international management consulting company McAlpine Thorpe and Warrier Ltd, which specializes in the field of herbal medicines, has announced...

STOCK MARKET COMMENTARY: EUROPE

6 April 1992

EUROPE: saw most bourses weak at the start of the reporting period, but strengthen as time went on. By the...

REDUCING ASTHMA COSTS IN THE USA

6 April 1992

A study looking at the economic aspect of asthma in the USA has found that there are a number of...

PHARMA COs TOP R&D SPEND IN JAPAN

6 April 1992

Of 16 Japanese companies planning to spend over 10% of their sales on R&D in 1992, nine are pharmaceutical companies,...

NEW EDITOR OF D&TB

6 April 1992

Joe Collier, reader and consultant in clinical pharmacology at St George's Hospital Medical School, London, has been appointed editor of...

ARIAD PHARMACEUTICALS STOCK SALE

6 April 1992

The biotechnology concern Ariad Pharmaceuticals of the USA is reported to have raised $46 million in a private stock sale,...

NEW US IMPLANT REGULATIONS

6 April 1992

The US Food and Drug Adminis-ration plans to require manufacturers of high-risk medical devices to track new patients closely, so...

CORTECS' NSAID TARGETING STRATEGY

6 April 1992

Researchers at UK-based Cortecs Limited have published results of studies in volunteers concerning its technology aimed at improving the bioavailability...

GERMAN POLICY UNDER FIRE

6 April 1992

German Health Minister Gerda Hasselfeldt has accused the leading German doctors' organization, the Hartmannbund, of political agitation, after it held...

Showing 94511-94520 of 95337 articles